441 related articles for article (PubMed ID: 19741534)
1. Utility of the virtual crossmatch in solid organ transplantation.
Amico P; Hönger G; Steiger J; Schaub S
Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
[TBL] [Abstract][Full Text] [Related]
4. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
8. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
9. Clinical cytometry and progress in HLA antibody detection.
Bray RA; Tarsitani C; Gebel HM; Lee JH
Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
[TBL] [Abstract][Full Text] [Related]
10. Positive virtual crossmatch with negative flow crossmatch results in two cases.
Jacob EK; De Goey SR; Gandhi MJ
Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
[TBL] [Abstract][Full Text] [Related]
11. The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients.
Jackson AM
Clin Transpl; 2014; ():131-6. PubMed ID: 26281137
[TBL] [Abstract][Full Text] [Related]
12. The changing role of antibody testing in transplantation.
Leffell MS; Montgomery RA; Zachary AA
Clin Transpl; 2005; ():259-71. PubMed ID: 17424745
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of circulating donor-specific HLA antibodies.
Claas FH
Curr Opin Organ Transplant; 2010 Aug; 15(4):462-6. PubMed ID: 20613523
[TBL] [Abstract][Full Text] [Related]
14. The evolution and clinical impact of human leukocyte antigen technology.
Gebel HM; Bray RA
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):598-602. PubMed ID: 20720491
[TBL] [Abstract][Full Text] [Related]
15. Utility of virtual crossmatch in sensitized patients awaiting heart transplantation.
Stehlik J; Islam N; Hurst D; Kfoury AG; Movsesian MA; Fuller A; Delgado JC; Hammond ME; Gilbert EM; Renlund DG; Bader F; Fisher PW; Bull DA; Singhal AK; Eckels DD
J Heart Lung Transplant; 2009 Nov; 28(11):1129-34. PubMed ID: 19782589
[TBL] [Abstract][Full Text] [Related]
16. The crossmatch may still be the most clinically relevant histocompatibility test performed.
Kerman R; Lappin J; Kahan B; Katz S; McKissick E; Hosek K; Acorda N; Wooley N; Hoover A; Miller K; Rodriguez L; Moore B; Melcher P; Biedermann B; Van Buren C
Clin Transpl; 2007; ():227-9. PubMed ID: 18642454
[TBL] [Abstract][Full Text] [Related]
17. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
[TBL] [Abstract][Full Text] [Related]
18. [Histocompatibility tests in a transplantation program].
de-Leo-Cervantes C
Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
[TBL] [Abstract][Full Text] [Related]
19. The DQ barrier: improving organ allocation equity using HLA-DQ information.
Tambur AR; Leventhal JR; Zitzner JR; Walsh RC; Friedewald JJ
Transplantation; 2013 Feb; 95(4):635-40. PubMed ID: 23288109
[TBL] [Abstract][Full Text] [Related]
20. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
